NCT00230750 - Inactivated Influenza A/H5N1 Vaccine in the Elderly | Biotech Hunter

Enrollment

261

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions

Influenza

Interventions

BIOLOGICAL

Influenza A/H5N1 Vaccine

Monovalent subvirion H5N1 vaccine (HA of A/Vietnam/1203/04) provided in unit-dose vials containing 90-mcg/mL. Dosages: 45 mcg or 90 mcg administered intramuscularly.

DRUG

Placebo

Saline placebo.

Trial Locations (4)

90502

UCLA Center For Vaccine Research, Torrance

14642-0001

University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

37232-2573

Vanderbilt University, Nashville

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH